:

INSTACART ACQUIRES COLOMBIAN GROCERY TECH FIRM INSTALEAP

INDUSTRY DESK1 MIN READ
TUE, APR 14, 2026

Instacart has acquired Instaleap, a Colombian grocery technology company, as part of its international expansion strategy. The deal marks the company's continued push to grow its operations beyond the United States.

The acquisition strengthens Instacart's footprint in Latin America, where demand for rapid grocery delivery continues to rise. Instaleap operates in multiple countries across the region and has built technology for managing grocery fulfillment and logistics. Instacart, which went public in 2023, has faced pressure to diversify revenue streams beyond its core US market. The company already operates in Canada and has explored opportunities across Europe and other regions. The financial terms of the deal were not disclosed. Instaleap's technology and team will integrate into Instacart's international operations, helping the platform expand its delivery capabilities in Latin America. The move reflects broader consolidation in the grocery delivery sector, where companies are building scale through acquisitions while expanding geographically.

■ MORE FROM THE BUSINESS DESK

The UK government has dismissed Green party leader Zack Polanski's proposal for a moratorium on large-scale AI datacentre construction, citing economic concerns over the energy and water-intensive projects.

3H AGOAI Desk

ChangXin Memory Technologies (CXMT), China's leading memory chip producer, filed a lawsuit against the Pentagon on Friday challenging its designation as a Chinese military company. CXMT denies military affiliation and claims its chips are for civilian use only.

3H AGOIndustry Desk

A US appeals court has ruled against Kalshi's attempt to block Nevada from regulating its platform, determining that the prediction market platform cannot escape state gambling laws by rebranding bets as 'swaps.'

3H AGOIndustry Desk

Vijay Pande has left Andreessen Horowitz's $4 billion biotech practice to launch VZVC, a smaller AI-native venture fund focused on transforming drug discovery through engineering principles rather than traditional discovery methods.

3H AGOIndustry Desk

■ SUBSCRIBE TO THE DAILY BRIEF

ONE EMAIL, 5 STORIES, 06:00 UTC. UNSUBSCRIBE ANYTIME.